AIL
BLUE

AGF Investments LLC’s bluebird bio BLUE Stock Holding History

AGF Investments LLC’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,666
Closed -$660K – 441
2021
Q3 		$660K Buy
+2,666
New +$762K 0.07% 81
2018
Q4 		– Sell
-12
Closed -$22K – 696
2018
Q3 		$22K Sell
12
-5
-29% -$10.3K ﹤0.01% 581
2018
Q2 		$35 Buy
+17
New +$38.7K ﹤0.01% 522
2018
Q1 		– Sell
-9
Closed -$20K – 680
2017
Q4 		$20K Buy
9
+3
+50% +$6.09K ﹤0.01% 434
2017
Q3 		$10K Sell
6
-8
-57% -$11.2K ﹤0.01% 504
2017
Q2 		$19K Sell
14
-2
-13% -$2.41K ﹤0.01% 367
2017
Q1 		$19K Buy
+16
New +$16.3K ﹤0.01% 371

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AGF Investments LLC's BLUE Position: Q4 2021 in Review

AGF Investments LLC sold out of bluebird bio (BLUE) in Q4 2021, closing a stake of 2,666 shares — an estimated $660K sold.

AGF Investments LLC first reported a position in BLUE in Q1 2017 and held it in 7 quarters. The position peaked at $660K in Q3 2021. 172 funds tracked by Wall St. Rank hold BLUE as of Q4 2021.

  • AGF Investments LLC reported no remaining bluebird bio position as of Q4 2021 after selling out during the quarter.
  • AGF Investments LLC sold 2,666 bluebird bio shares in Q4 2021, an estimated $660K.
  • AGF Investments LLC first reported a position in bluebird bio in Q1 2017 and held it in 7 quarters.
  • AGF Investments LLC's bluebird bio position peaked at $660K in Q3 2021.
  • 172 funds tracked by Wall St. Rank held bluebird bio as of Q4 2021.

Based on AGF Investments LLC's 13F filing for Q4 2021, filed 1 Feb 2022.